🇺🇸 TPO in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Asthenia — 1 report (10%)
- Bone Marrow Failure — 1 report (10%)
- Cerebral Haemorrhage — 1 report (10%)
- Circulatory Collapse — 1 report (10%)
- Cytopenia — 1 report (10%)
- Diarrhoea — 1 report (10%)
- Drug Ineffective — 1 report (10%)
- Erythropoiesis Abnormal — 1 report (10%)
- Febrile Neutropenia — 1 report (10%)
- Granulocyte Count Decreased — 1 report (10%)
Other Hematology approved in United States
Frequently asked questions
Is TPO approved in United States?
TPO does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for TPO in United States?
Shenyang Sunshine Pharmaceutical Co., LTD. is the originator. The local marketing authorisation holder may differ — check the official source linked above.